Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00164697 · ClinicalTrials.gov registry record · NA
Legacy for Children, an Early Intervention Study to Promote Optimal Child Development in Low-income Families
A NA study, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- NA
- Development phase
- 547
- Enrollment target
NCT00164697: Completed NA study, sponsored by Centers for Disease Control and Prevention.
NCT00164697 is a NA study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 547 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00164697, a NA study, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- NA
- Development phase
- 547 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if an intervention focused on promoting parent-child interaction, parental responsibility, parental commitment of time and energy, and sense of community results in better developmental outcomes for low-income children.
Interventions
- BEHAVIORAL Parenting group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 547 participants |
| Start Date | 1999-10 |
| Est. Completion | 2013-02 |
| Phase | NA |
What the finished NCT00164697 record still lists
NCT00164697 is an interventional study that assigns participants to a tested intervention. The registered 547 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% lower).
The record links to 0 conditions, and to 1 intervention - of which Parenting group is the first listed.
NCT00164697 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00164697 about?
NCT00164697 is a clinical study titled "Legacy for Children, an Early Intervention Study to Promote Optimal Child Development in Low-income Families". The purpose of this study is to determine if an intervention focused on promoting parent-child interaction, parental responsibility, parental commitment of time and energy, and sense of community results in better developmental outcomes for low-income children.
What is the current status of trial NCT00164697?
This trial is currently completed. It is a NA study. The enrollment target is 547 participants. The study started on 1999-10. Estimated completion is 2013-02.
What interventions are being tested in trial NCT00164697?
The interventions under investigation include: Parenting group (BEHAVIORAL).
Who is sponsoring clinical trial NCT00164697?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00164697's enrollment target sits among peer trials
547 186th of 2000 higher than 1,815 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03572374 · 546 participants · NA
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job
- NCT05937685 · 546 participants · NA
Reducing Blood Pressure in Patients With High Cardiovascular Risk
- NCT06416150 · 546 participants · NA
Reducing Urban Cervical Cancer Disparities
- NCT06850922 · 546 participants · Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia